UK markets closed

Brainstorm Cell Therapeutics Inc. (GHDN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.5190-0.0420 (-7.49%)
At close: 08:23AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
11,499
13,956
15,235
22,329
17,204
Selling general and administrative
10,051
10,866
9,304
9,355
5,797
Total operating expenses
21,550
24,822
24,539
31,684
23,001
Operating income or loss
-21,550
-24,822
-24,539
-31,684
-23,001
Income before tax
-16,632
-24,277
-24,457
-31,811
-23,253
Income from continuing operations
-16,632
-24,277
-24,457
-31,811
-23,253
Net income
-16,632
-24,277
-24,457
-31,811
-23,253
Net income available to common shareholders
-16,632
-24,277
-24,457
-31,811
-23,253
Basic EPS
-0.42
-0.66
-0.68
-1.07
-1.06
Diluted EPS
-0.42
-0.66
-0.68
-1.07
-1.06
Basic average shares
39,346
36,509
36,182
29,848
21,906
Diluted average shares
39,346
36,509
36,182
29,848
21,906